Answers are grounded in this paper and cite their sources.
KEYWORDS: measurable residual diseaseBCR:ABL1next-generation sequencingpolymerase chain reactionprognosisrisk stratification
No takes yet. Share an insight, caveat, or question.
Short et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: